Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5889 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Purinergic Signaling in the Pathophysiology and Treatment of Huntington's Disease

Wiprich MT, Bonan CD.

Front Neurosci. 2021 Jul 1;15:657338. doi: 10.3389/fnins.2021.657338. eCollection 2021.

A Brief Review on the Role of Vesicular Monoamine Transporter(2) Inhibitors in Hyperkinetic Movement Disorders

Nikkhah A.

Iran J Child Neurol. 2021 Summer;15(3):29-33. doi: 10.22037/ijcn.v15i3.33144.

Pallidal degenerations and related disorders: an update

Jellinger KA.

J Neural Transm (Vienna). 2022 Jun;129(5-6):521-543. doi: 10.1007/s00702-021-02392-2. Epub 2021 Aug 7.

Mood and emotional disorders associated with parkinsonism, Huntington disease, and other movement disorders

Bono AD, Twaite JT, Krch D, McCabe DL, Scorpio KA, Stafford RJ, Borod JC.

Handb Clin Neurol. 2021;183:175-196. doi: 10.1016/B978-0-12-822290-4.00015-3.

A Curious Case of Excessive Winking

Medarametla S, Boraiah N, Raju S.

Mov Disord Clin Pract. 2021 May 29;8(6):947-949. doi: 10.1002/mdc3.13254. eCollection 2021 Aug.

Acute Movement Disorders in Childhood: A Cohort Study and Review of the Literature

Benrhouma H, Nasri A, Klaa H, Ben Achour N, Rouissi A, Kraoua I, Turki I.

Pediatr Emerg Care. 2021 Nov 1;37(11):e719-e725. doi: 10.1097/PEC.0000000000002017.

Brain F-18 FDG and F-18 FP-CIT PET/CT Findings of c.856_860delCTCTA Mutation McLeod Syndrome

Ryu HS, Hong CM.

Cogn Behav Neurol. 2021 Sep 2;34(3):207-211. doi: 10.1097/WNN.0000000000000267.

Mitochondrial Abnormalities and Synaptic Damage in Huntington's Disease: a Focus on Defective Mitophagy and Mitochondria-Targeted Therapeutics

Sawant N, Morton H, Kshirsagar S, Reddy AP, Reddy PH.

Mol Neurobiol. 2021 Dec;58(12):6350-6377. doi: 10.1007/s12035-021-02556-x. Epub 2021 Sep 14.

Growth hormone deficiency in a child with benign hereditary chorea caused by a de novo mutation of the TITF1/NKX2-1 gene

Trevisani V, Predieri B, Madeo SF, Fusco C, Garavelli L, Caraffi S, Iughetti L.

J Pediatr Endocrinol Metab. 2021 Oct 28;35(3):411-415. doi: 10.1515/jpem-2021-0402. Print 2022 Mar 28.

An MDS Evidence-Based Review on Treatments for Huntington's Disease

Ferreira JJ, Rodrigues FB, Duarte GS, Mestre TA, Bachoud-Levi AC, Bentivoglio AR, Burgunder JM, Cardoso F, Claassen DO, Landwehrmeyer GB, Kulisevsky J, Nirenberg MJ, Rosser A, Roth J, Seppi K, Slawek J, Furr-Stimming E, Tabrizi SJ, Walker FO, Vandenberghe W, Costa J, Sampaio C.

Mov Disord. 2022 Jan;37(1):25-35. doi: 10.1002/mds.28855. Epub 2021 Nov 29.

Non-Ketotic Hyperglycemic Hemichorea-Hemiballismus in the Setting of Antipsychotics and Methamphetamine

Nelson CC, Ohnoutka C, Ulen M.

Cureus. 2021 Oct 28;13(10):e19094. doi: 10.7759/cureus.19094. eCollection 2021 Oct.

Therapeutic application of rTMS in neurodegenerative and movement disorders: A review

Pateraki G, Anargyros K, Aloizou AM, Siokas V, Bakirtzis C, Liampas I, Tsouris Z, Ziogka P, Sgantzos M, Folia V, Peristeri E, Dardiotis E.

J Electromyogr Kinesiol. 2022 Feb;62:102622. doi: 10.1016/j.jelekin.2021.102622. Epub 2021 Nov 26.

Treatable Hyperkinetic Movement Disorders Not to Be Missed

Méneret A, Garcin B, Frismand S, Lannuzel A, Mariani LL, Roze E.

Front Neurol. 2021 Dec 1;12:659805. doi: 10.3389/fneur.2021.659805. eCollection 2021.

Case Report: Long-Term Suppression of Paroxysmal Kinesigenic Dyskinesia After Bilateral Thalamotomy

Murakami M, Horisawa S, Azuma K, Akagawa H, Nonaka T, Kawamata T, Taira T.

Front Neurol. 2021 Dec 3;12:789468. doi: 10.3389/fneur.2021.789468. eCollection 2021.

Quality of Life After Deep Brain Stimulation of Pediatric Patients with Dyskinetic Cerebral Palsy: A Prospective, Single-Arm, Multicenter Study with a Subsequent Randomized Double-Blind Crossover (STIM-CP)

Koy A, Kühn AA, Huebl J, Schneider GH, van Riesen AK, Eckenweiler M, Rensing-Zimmermann C, Coenen VA, Krauss JK, Saryyeva A, Hartmann H, Haeussler M, Volkmann J, Matthies C, Horn A, Schnitzler A, Vesper J, Gharabaghi A, Weiss D, Bevot A, Marks W, Pomykal A, Monbaliu E, Borck G, Mueller J, Prinz-Langenohl R, Dembek T, Visser-Vandewalle V, Wirths J, Schiller P, Hellmich M, Timmermann L; STIM-CP investigators.

Mov Disord. 2022 Apr;37(4):799-811. doi: 10.1002/mds.28898. Epub 2021 Dec 29.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias